Medical/Pharmaceuticals

Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China

SAN FRANCISCO and SUZHOU, China, Aug. 5, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2026-08-06 08:00 3849

Telix to Host R&D Day in New York City on September 22, 2026

MELBOURNE, Australia and INDIANAPOLIS, Aug. 6, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will host a Research and Development (R&D) Day on Tuesday, September 22, 2026, from 8:30 a.m. to 12:30 p.m. EDT in New York City. Institutional...

2026-08-06 05:00 2293

NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...

2026-08-05 21:15 4357

Nearly 3 in 10 Veterinarians at Japan's Larger Companion-Animal Hospitals Say Their Current Pace Is Unsustainable, Zpeer Survey Finds

TOKYO, August 5, 2026 /PRNewswire/ -- Zpeer Inc., operator of Vetpeer — Japan's largest online community for veterinary professionals, reaching approximately 80% of the country's small-animal veterinarians —today released the results of a survey of 314 companion-animal veterinarians on their work...

2026-08-05 21:00 2878

KPJ Healthcare and SingHealth Mark Strategic Partnership to Strengthen Future Healthcare Capabilities

JOHOR BAHRU, Malaysia, Aug. 5, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare") marked the commencement of a strategic partnership with SingHealth, Singapore's largest and leading healthcare cluster, through the signing of a Memorandum of Understanding ("MoU"), establishing a long-te...

2026-08-05 20:53 3391

KPJ Healthcare and SingHealth Mark Strategic Partnership to Strengthen Future Healthcare Capabilities

JOHOR BAHRU, Malaysia, Aug. 5, 2026 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare") marked the commencement of a strategic partnership with SingHealth, Singapore's largest and leading healthcare cluster, through the signing of a Memorandum of Understanding ("MoU"), establishing a long-te...

2026-08-05 20:30 3052

Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization

CRANBURY, N.J. and SUZHOU,China, Aug. 5, 2026 /PRNewswire/ -- Recently, Porton Advanced Solutions Ltd. ("Porton Advanced") has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA).This milestone qualifies Porton Advanced to undertak...

2026-08-05 20:00 1847

Leading the Future of Oral Delivery, Lonza Capsugel brings breakthrough Capsule Technologies to the Korean Market at CPHI Korea

Advanced Capsule Technology for Improved Digestive Enzyme Delivery SEOUL, South Korea, Aug. 5, 2026 /PRNewswire/ -- Lonza Capsugel has released new peer-reviewed research showing that its Licaps® DUOCAP® capsule-in-capsule technology can significantly improve the protection and targeted deliv...

2026-08-05 18:39 2966

Everest Medicines to Announce 2026 Interim Results and Host Online Investor Call on August 19, 2026

SHANGHAI, Aug. 5, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its interim result...

2026-08-05 17:37 1966

Sisram Medical to Announce 2026 Interim Results on Wednesday, August 19, 2026

Earnings Conference Call to be Held on August 20, 2026 HONG KONG, Aug. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or " Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced that it will repo...

2026-08-05 17:19 1689

NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing

SAN DIEGO, Aug. 5, 2026 /PRNewswire/ -- NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused on advancing modern cell therapies from scientific discovery through clinical readiness, tod...

2026-08-05 15:00 1791

Shanghai SinoUnited Hospital Announced Availability of World's First CAR-T Therapy for Solid Tumors in Advanced Gastric Cancer

SHANGHAI, Aug. 5, 2026 /PRNewswire/ -- Shanghai SinoUnited Hospital today announced the availability of satricabtagene autoleucel ("satri-cel"), the world's first chimeric antigen receptor (CAR) T-cell therapy approved for the treatment of solid tumors, for eligible patients with Claudin18.2-posi...

2026-08-05 14:06 1423

Sisram Medical Launches Titanium Prime Treatment Concept in Hong Kong SAR

Harnessing dual-device synergies, multi-energy technologies, and pioneering layered protocols, Sisram cements its strategic leadership across APAC HONG KONG, Aug. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices...

2026-08-05 12:11 1966

Singapore Startup Genie Health Launches Personal Health Intelligence Platform for Consumers and Healthcare Providers

SINGAPORE, Aug. 5, 2026 /PRNewswire/ -- As people live longer and chronic conditions become increasingly common, managing health has quietly become more complex than ever before. Consumers now juggle medical reports, health screenings, wearable devices, medications and advice from multiple provid...

2026-08-05 11:05 2960

JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results

CHANGZHOU, China, Aug. 4, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, today announced its unaudit...

2026-08-05 04:30 4548

NIPRO Launches Expanded Hemodialysis with ELISIO™-HX to U.S. Providers Following FDA Clearance

Now commercially available, the medium cut-off dialyzer expands access to enhanced middle molecule removal through existing dialysis infrastructure OSAKA, Japan and BRIDGEWATER, N.J., Aug. 4, 2026 /PRNewswire/ -- NIPRO CORPORATION, through its U.S.-based subsidiary Nipro Medical Corporation, toda...

2026-08-04 22:01 2502

72 patient multi-indication trial approved to fast track TRP-8803 commercialisation

* Human Research Ethics Committee (HREC) approval secured for world-first phase 1b/2a 8-indication basket study across in 72-patients of TRP-8803 * Study will evaluate TRP-8803 (IV-infused psilocin) across eight major disorders with high unmet treatment needs in a single clinical framework *...

2026-08-04 22:00 2674

NYSE Content Update: ADI to Make NYSE Trading Debut After Spin-Off

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...

2026-08-04 20:55 5186

AsymBio Secures US$184 Million Capital Injection to Support Long-Term Growth

SHANGHAI, Aug. 4, 2026 /PRNewswire/ -- AsymBio , a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary ofAsymchem Group (stock codes: 002821.SZ / 6821.HK), today announced a total capital injection of ...

2026-08-04 20:30 4005

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS  (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deplo...

2026-08-04 18:15 2277
1 ... 6789101112 ... 645